News

Filter

Current filters:

defactinib

Defactinib plus paclitaxel positive in platinum-resistant ovarian cancer

23-07-2013

US cancer drug developer Verastem (Nasdaq: VSTM) has announced the confirmation of a complete response…

BiotechnologydefactinibOncologyResearchVerastem

COMPANY SPOTLIGHT

Menarini

Back to top